Elder Pharmacology

Studying and treating the chronic diseases associated with aging needs serious revamping.

Written byNir Barzilai
| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

© MICHAEL SLOAN/THEISPOT

What is the greatest menace associated with age-related diseases? Hypertension? Obesity? High cholesterol? No. It’s simply the number of years an individual lives.

For example, elevated plasma cholesterol is considered a major risk factor for cardiovascular-disease death. Yet, when compared with aging itself, the risk of high cholesterol alone pales. For a typical adult, high cholesterol poses a threefold increase in the risk of dying from cardiovascular disease. Simply aging from 35 to 85, however, increases that risk about a thousand fold.

Similar patterns are observed for cancer, type 2 diabetes, and Alzheimer’s disease. National Institutes of Health data indicate that the risk of dying from these diseases accelerates logarithmically by approximately 100 to 1,000-fold between ages 35 and 85. No wonder so many elderly ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies